ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate CancerZhe Tang, Timothy C. Thompson, Patrick G. Pilié et al.|Clinical Cancer Research|2021Cited by 145
PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Timothy C. Thompson, Likun Li et al.|Clinical Cancer Research|2019Cited by 78
Maintenance Therapy With Continuous or Switch Strategy in Advanced Non-small Cell Lung CancerXinji Zhang, Jia He, Jinfang Xu et al.|CHEST Journal|2011Cited by 71
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Timothy C. Thompson, Zhe Tang et al.|Molecular Cancer Therapeutics|2021Cited by 58
Trends in In-Hospital Mortality among Patients with Stroke in ChinaQian He, Jia He, Cheng Wu et al.|PLoS ONE|2014Cited by 47